Advertisement

Prevention and Management of Hepatitis B in Healthcare Professionals

  • Corey R. O’Brien
  • Joseph K. LimEmail author
Hepatitis B (J Lim, Section Editor)
  • 9 Downloads
Part of the following topical collections:
  1. Topical Collection on Hepatitis B

Abstract

Purpose of Review

To review the epidemiology of hepatitis B virus (HBV) transmission in the healthcare setting and outline best practices in the prevention and management of chronic HBV in healthcare professionals.

Recent Findings

Hepatitis B virus (HBV) infection remains a global public health burden and chronically infects an estimated 257 million persons worldwide. HBV represents one of the most important occupational risks for healthcare workers (HCWs) due to efficient transmission through percutaneous exposure of HBV-infected blood and blood-contaminated body fluids. Although the incidence of HCW-patient transmission of HBV has decreased significantly since 2000, ongoing deficits in HCW testing, vaccination, and confirmation of immunity, as well as post-exposure management protocols, raise concern for ongoing risk for nosocomial exposure.

Summary

Established recommendations of the AASLD, CDC, and SHEA provide guidance to clinicians on the prevention and management of chronic HBV in healthcare professionals.

Keywords

Hepatitis B Healthcare professionals Needlestick injury Occupational health Vaccination 

Notes

Compliance with Ethical Standards

Conflict of Interest

Joseph K. Lim reports grants from AbbVie, grants from Allergan, grants and personal fees from Bristol-Myers Squibb, grants from Conatus, grants from Genfit, grants from Gilead, grants from Intercept, outside the submitted work. Corey R. O’Brien declares no potential conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    World Health Organization. Global Hepatitis Report 2017. Geneva: World Health Organization; 2017.Google Scholar
  2. 2.
    Chang MS, Nguyen MH. Epidemiology of hepatitis B and the role of vaccination. Best Pract Res Clin Gastroenterol. 2017;31:239–47.CrossRefGoogle Scholar
  3. 3.
    •• Schillie S, Vellozzi C, Reingold A, et al. Prevention of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep. 2018;67:1–31. National guideline recommendations for hepatitis B immunization by the U.S. Advisory Committee on Immunization Practices (ACIP). CrossRefGoogle Scholar
  4. 4.
    Weinbaum CM, Williams I, Mast EE, Wang SA, Finelli L, Wasley A, et al. Recommendations for identification and public health management of persons with chronic hepatitis B infection. MMWR Recomm Rep. 2008;57(RR08):1–20.Google Scholar
  5. 5.
    Dienstag J. Hepatitis B virus infection. NEJM. 2008;359:1486–500.CrossRefGoogle Scholar
  6. 6.
    Van der Eijk A, et al. Hepatitis B virus (HBV) DNA levels and the management of HBV-infected health care workers. J Viral Hepat. 2006;13:2–4.CrossRefGoogle Scholar
  7. 7.
    Nguyen MH, Lim JK, Ozbay AB, Fraysse J, Liou I, Meyer N, et al. Advancing age and comorbidity in a United States insured population-based cohort of patients with chronic hepatitis B. Hepatology. 2018 Sep 2 [Epub ahead of print].Google Scholar
  8. 8.
    Viral Hepatitis Statistics and Surveillance. Centers for Disease Control and Prevention. 2016. https://www.cdc.gov/hepatitis/hbv/statisticshbv.htm. Accessed 13 Aug 13 2018.
  9. 9.
    Hasak JM, Novak CB, Patterson JM, Mackinnon SE. Prevalence of needlestick injuries, attitude changes, and prevention practices over 12 years in an urban academic hospital surgery department. Ann Surg. 2018;267:291–6.CrossRefGoogle Scholar
  10. 10.
    Nguyen MH, Ozbay AB, Liou I, Meyer N, Gordon SC, Dusheiko G, et al. Healthcare resource utilization and costs by disease severity in an insured national sample of US patients with chronic hepatitis B. J Hepatol. 2019;70:24–32.Google Scholar
  11. 11.
    • Schillie S, Murphy TV, Sawyer M, et al. CDC guidance for evaluating health-care personnel for hepatitis B virus protection and for administering postexposure management. MMWR Recomm Rep. 2013;62(RR-10):1–19. National guideline recommendations of the U.S. CDC for prevention and management of occupational HBV exposure in health care workers. Google Scholar
  12. 12.
    Coppola N. Hepatitis B virus and hepatitis C virus infection in healthcare workers. World J Hepatol. 2016;8(5):273–81.CrossRefGoogle Scholar
  13. 13.
    Stotka JL, Wong ES, Williams DS, Stuart CG, Markowitz SM. An analysis of blood and body fluid exposures sustained by house officers, medical students, and nursing personnel in acute-care general medical wards: a prospective study. Infect Control Hosp Epidemiol. 1991;12:583–90.CrossRefGoogle Scholar
  14. 14.
    Resnic F, Noerdlinger M. Occupational exposure among medical student and house staff at a New York City medical center. Arch Intern Med. 1995;155:75–80.CrossRefGoogle Scholar
  15. 15.
    • Henderson D. SHEA guideline for management of healthcare workers who are infected with hepatitis B virus, hepatitis C, and/or HIV. Infect Control Hosp Epidemiol. 2010;31(3):203–32. National recommendations of the Society for Healthcare Epidemiology of America (SHEA) governing the management of healthcare workers with occupational exposure to HBV, HCV, and HIV. CrossRefGoogle Scholar
  16. 16.
    Riddell A, Kennedy I, Tong CYW. Management of sharps injuries in the healthcare setting. BMJ. 2015;351:h3733.CrossRefGoogle Scholar
  17. 17.
    • Centers for Disease Control and Prevention. Immunization of health-care personnel: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2011;60(RR-7):1–45. National recommendations of the U.S. Advisory Committee on Immunization Practices (ACIP) for immunizations in healthcare workers. Google Scholar
  18. 18.
    Centers for Disease Control and Prevention. Updated CDC recommendations for the management of hepatitis B virus-infected health-care providers and students. MMWR Recomm Rep. 2012;61(RR-3):1–12.Google Scholar
  19. 19.
    CDC. Recommendations for preventing transmission of human immunodeficiency virus and hepatitis B virus to patients during exposure-prone invasive procedures. MMWR Recomm Rep. 1991;40:1–9.Google Scholar
  20. 20.
    • Lewis J. Hepatitis B in healthcare workers: transmission events and guidance for management. World J Hepatol. 2015;7(3):488–97. A detailed review and characterization of cases of HBV transmission in healthcare workers. CrossRefGoogle Scholar
  21. 21.
    CDC. Update: universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other bloodborne pathogens in health-care settings. MMWR Morb Mortal Wkly Rep. 1988;37:377–82.Google Scholar
  22. 22.
    Schillie S, Vellozzi C, Reingold A, Harris A, Haber P, Ward JW. Prevention of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep. 2018;67(1):1–31.CrossRefGoogle Scholar
  23. 23.
    Bond WW, Favero MS, Petersen NJ, Gravelle CR, Ebert JW, Maynard JE. Survival of hepatitis B virus after drying and storage for one week. Lancet. 1981;317:550–1.CrossRefGoogle Scholar
  24. 24.
    Maniar H, Tawari A, Suk M, Bowen T, Horwitz D. Percutaneous and mucocutaneous exposure among orthopedic surgeons: immediate management and compliance with CDC protocol. J Orthop Trauma. 2015;29(10):391–5.CrossRefGoogle Scholar
  25. 25.
    Byrd KK, Lu PJ, Murphy TV. Hepatitis B vaccination coverage among health-care personnel in the United States. Public Health Rep. 2013;128:498–509.CrossRefGoogle Scholar
  26. 26.
    CDC. Recommendation of the Immunization Practices Advisory Committee (ACIP): inactivated hepatitis B virus vaccine. MMWR Morb Mortal Wkly Rep. 1982;31:317–22 327–328.Google Scholar
  27. 27.
    Tatelbaum MF. Needlestick safety and prevention act. Pain Physician. 2001;4:193–5.Google Scholar
  28. 28.
    CDC. Update on adult immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 1991;40(RR-12):1–94.Google Scholar
  29. 29.
    •• Terrault NA, Lok ASF, McMahon BJ, Chang KM, Hwang JP, Jonas MM, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67:1560–9. A national guideline of the American Association for the Study of Liver Diseases (AASLD) for the management of chronic hepatitis B infection. CrossRefGoogle Scholar
  30. 30.
    Tohme RA, Ribner B, Huey MJ, Spradling PR. Hepatitis B vaccination coverage and documented seroprotection among matriculating healthcare students at an academic institution in the United States. Infect Control Hosp Epidemiol. 2011;32:818–21.CrossRefGoogle Scholar
  31. 31.
    Tawk HM, Vickery K, Bisset L, Selby W, Cossart YE, Infection in endoscopy study group. The impact of hepatitis B vaccination in a Western country: recall of vaccination and serological status in Australian adults. Vaccine. 2006;24:1095–106.CrossRefGoogle Scholar
  32. 32.
    Lindley MC, Lorick SA, Spinner JR, Krull AR, Mootrey GT, Ahmed F, et al. Student vaccination requirements of U.S. health professional schools: a survey. Ann Intern Med. 2011;154(6):391–400.CrossRefGoogle Scholar
  33. 33.
    CDC. FDA approval for infants of a haemophilus influenzae type B conjugate and hepatitis B (recombinant) combined vaccine. MMWR Morb Mortal Wkly Rep. 1997;46:107–9.Google Scholar
  34. 34.
    Siegel JD, Rhinehart E, Jackson M, Chiarello L. 2007 guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Am J Infect Control. 2007;35(Suppl 2):S65–S164.CrossRefGoogle Scholar
  35. 35.
    US Department of Labor, Occupational Safety and Health Administration. Bloodborne Pathogens. 29 CFR §1910.1030 (1991).Google Scholar
  36. 36.
    Lampertico P, Agarwal K, Berg T, Buti M, Jansen HLA, Papatheodoridis G, et al. EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67:370–98.CrossRefGoogle Scholar
  37. 37.
    Martin P, Lau DT, Nguyen MH, Janssen HL, Dieterich DT, Peters MG, et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2015 update. Clin Gastroenterol Hepatol. 2015;13:2071–87.CrossRefGoogle Scholar
  38. 38.
    Tong MJ, Pan CQ, Han SB, Lu DS, Raman S, Hu KQ, et al. An expert consensus for the management of chronic hepatitis B in Asian Americans. Aliment Pharmacol Ther. 2018;47:1181–200.CrossRefGoogle Scholar
  39. 39.
    Enfield K, Sharapov U, Hall K, et al. Transmission of hepatitis B virus from an orthopedic surgeon with a high viral load. Clin Infect Dis. 2013;56:218–24.CrossRefGoogle Scholar
  40. 40.
    Laurenson IF, Jones DG, Hallam NF, Saunders CJ, Fraser DM, Carman WF. Transmission of hepatitis B virus from a vaccinated healthcare worker. J Hosp Infect. 2007;66:393–4.CrossRefGoogle Scholar
  41. 41.
    Sugimoto S, Nagakubo S, Ito T, Tsunoda Y, Imamura S, Tamura T, et al. A case of acute hepatitis B related to previous gynecological surgery in Japan. J Infect Chemother. 2013;19:524–429.CrossRefGoogle Scholar
  42. 42.
    Harpaz R, Von Seidlein L, Averhoff FM, Tormey MP, Sinha SD, Kotsopoulou K, et al. Transmission of hepatitis B virus to multiple patients from a surgeon without evidence of inadequate infection control. N Engl J Med. 1996;334:549–54.CrossRefGoogle Scholar
  43. 43.
    American College of Surgeons. Statement on the surgeon and hepatitis B infection. Bull Am Coll Surg. 1995;80:33–5.Google Scholar
  44. 44.
    • American College of Surgeons. Statement on the surgeon and hepatitis. Bull Am Coll Surg. 2004;89:35–9. Updated recommendations of the American College of Surgeons in the management of hepatitis B in healthcare workers. Google Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Internal MedicineYale University School of MedicineNew HavenUSA
  2. 2.Yale Liver Center and Section of Digestive DiseasesYale University School of MedicineNew HavenUSA

Personalised recommendations